Anti-RANKL therapy limits periapical osteolysis but interfere with immunoregulatory response (2017)
Source: Journal of Dental Research. Conference titles: General Session & Exhibition of the IADR - International Association for Dental Research. Unidade: FOB
Subjects: INFLAMAÇÃO, LINFÓCITOS T, IMUNOLOGIA, DOENÇAS PERIAPICAIS
ABNT
FRANCISCONI, C. et al. Anti-RANKL therapy limits periapical osteolysis but interfere with immunoregulatory response. Journal of Dental Research. Alexandria: International Association for Dental Research. . Acesso em: 26 ago. 2024. , 2017APA
Francisconi, C., Vieira, A., Fonseca, A., Soriani, M., Trombone, A., Sfeir, C., et al. (2017). Anti-RANKL therapy limits periapical osteolysis but interfere with immunoregulatory response. Journal of Dental Research. Alexandria: International Association for Dental Research.NLM
Francisconi C, Vieira A, Fonseca A, Soriani M, Trombone A, Sfeir C, Little S, Garlet G. Anti-RANKL therapy limits periapical osteolysis but interfere with immunoregulatory response. Journal of Dental Research. 2017 ; 96 S Issue A.[citado 2024 ago. 26 ]Vancouver
Francisconi C, Vieira A, Fonseca A, Soriani M, Trombone A, Sfeir C, Little S, Garlet G. Anti-RANKL therapy limits periapical osteolysis but interfere with immunoregulatory response. Journal of Dental Research. 2017 ; 96 S Issue A.[citado 2024 ago. 26 ]